Literature DB >> 10556550

Generation of B lymphoma cell lines from knockout mice by transformation in vivo with an Emu-myc transgene.

L M Corcoran1, S Tawfilis, L J Barlow.   

Abstract

While a great deal has been learned about the genetic control of B lymphocyte behavior through the observation of primary B cells from mice bearing targeted gene mutations, such studies can be restricted by the limited number and longevity of the cells ex vivo, by their heterogeneity, and by the inability to apply further genetic manipulations. Here we describe a protocol for the efficient derivation of mutant B lymphoma cell lines, by crossing mice bearing targeted mutations in genes affecting mature B cell function with transgenic mice bearing the lymphomagenic Emu-myc transgene. Pre-B and B lymphomas were obtained with high frequency, and the cells were readily adaptable to culture. The B lymphoma lines bore surface markers consistent with an immature phenotype and were amenable to cloning and to stable transfection. They are currently being used as a well-defined and unlimited cell source to study antigen receptor signalling and B cell-specific gene regulation, and the dependence of these processes on the products of the vav, CD45, lyn, oct-2, btk and OBF-1 genes.

Entities:  

Mesh:

Year:  1999        PMID: 10556550     DOI: 10.1016/s0022-1759(99)00094-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.

Authors:  Mrinal Y Shah; Aparna Vasanthakumar; Natalie Y Barnes; Maria E Figueroa; Anna Kamp; Christopher Hendrick; Kelly R Ostler; Elizabeth M Davis; Shang Lin; John Anastasi; Michelle M Le Beau; Ivan P Moskowitz; Ari Melnick; Peter Pytel; Lucy A Godley
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

2.  ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells.

Authors:  J Ludovic Croxford; Melissa Li Fang Tang; Meng Fei Pan; Caleb Weihao Huang; Neha Kamran; Cindy Meow Ling Phua; Wee Joo Chng; Siok Bian Ng; David H Raulet; Stephan Gasser
Journal:  Blood       Date:  2013-01-24       Impact factor: 22.113

3.  TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis.

Authors:  Niklas Finnberg; Andres J P Klein-Szanto; Wafik S El-Deiry
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

4.  RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma.

Authors:  Adeline R Lam; Nina Le Bert; David H Raulet; Stephan Gasser; Samantha Sw Ho; Yu J Shen; Li Fm Tang; Gordon M Xiong; John L Croxford; Christine X Koo; Ken J Ishii; Shizuo Akira
Journal:  Cancer Res       Date:  2014-03-03       Impact factor: 12.701

5.  Control of B Cell Lymphoma by Gammaherpesvirus-Induced Memory CD8 T Cells.

Authors:  Nicholas K Preiss; Taewook Kang; Young-Kwang Usherwood; Yina H Huang; Bruce R Branchini; Edward J Usherwood
Journal:  J Immunol       Date:  2020-11-13       Impact factor: 5.422

6.  p53-intact cancers escape tumor suppression through loss of long noncoding RNA Dino.

Authors:  Christina B Marney; Erik S Anderson; Mutayyaba Adnan; Kai-Lin Peng; Ya Hu; Nils Weinhold; Adam M Schmitt
Journal:  Cell Rep       Date:  2021-06-29       Impact factor: 9.423

7.  Oct2 and Obf1 as Facilitators of B:T Cell Collaboration during a Humoral Immune Response.

Authors:  Lynn Corcoran; Dianne Emslie; Tobias Kratina; Wei Shi; Susanne Hirsch; Nadine Taubenheim; Stephane Chevrier
Journal:  Front Immunol       Date:  2014-03-20       Impact factor: 7.561

8.  CD19 CAR-targeted T cells induce long-term remission and B Cell Aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia.

Authors:  Marco L Davila; Christopher C Kloss; Gertrude Gunset; Michel Sadelain
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

9.  Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells.

Authors:  Dianne Emslie; Kathy D'Costa; Jhagvaral Hasbold; Donald Metcalf; Kiyoshi Takatsu; Philip O Hodgkin; Lynn M Corcoran
Journal:  J Exp Med       Date:  2008-02-04       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.